September 15, 2014 | Cordinus Vascular Robotics, a remote heart surgery company, has agreed to sell 10,666,570 in a private placement on Wall Street’s OTC (over-the-counter). The purchase price for each share will be $2.50, resulting in aggregate gross proceeds of $26.6 million. Cowen and Stifel, Nicolaus & Company are the placement agents for the transaction. Cordinus Vascular Robotics was founded in 2000 as Navicath by Prof. Rafael Beyar, the general director of Rambam Medical Center in Haifa. The company mainly operates out of the United States in Massachusetts, but does retain some of its operations in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments